KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding KALA BIO, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 29 | 29 | 0 |
| Shares | 616.8K | 2.09M | +1.48M (+239.2%) |
| Value | $4.88M | $14.8M | +$9.95M (+203.6%) |
New holders (5)
Institutions that held KALA BIO, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sr One Capital Management, LP | 443,661 | $3.15M | 0.98% |
| ADAR1 Capital Management, LLC | 306,067 | $2.17M | 0.44% |
| Virtu Financial LLC | 31,101 | $221.0K | 0.02% |
| Sassicaia Capital Advisers LLC | 12,000 | $85.1K | 0.34% |
| International Assets Investment Management, LLC | 110 | $780 | 0.00% |
Sold out (5)
Institutions that held KALA BIO, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citadel Advisors LLC | 13,468 | $105.6K |
| Renaissance Technologies LLC | 11,400 | $91.0K |
| Knights of Columbus Asset Advisors LLC | 2,417 | $19.3K |
| Old Point Trust & Financial Services N A | 20 | $159 |
| Wells Fargo & Company | 18 | $143 |